INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,661 | -18.2% | 5,081 | +5.5% | 0.01% | -20.0% |
| Q2 2023 | $196,478 | +17.8% | 4,818 | +7.7% | 0.01% | +11.1% |
| Q1 2023 | $166,746 | -9.0% | 4,474 | -14.8% | 0.01% | +12.5% |
| Q4 2022 | $183,207 | -28.0% | 5,251 | +15.5% | 0.01% | -38.5% |
| Q3 2022 | $254,506 | +8.1% | 4,548 | 0.0% | 0.01% | +30.0% |
| Q2 2022 | $235,404 | -25.9% | 4,548 | +4.0% | 0.01% | -9.1% |
| Q1 2022 | $317,713 | -84.8% | 4,372 | -75.3% | 0.01% | -60.7% |
| Q4 2021 | $2,094,030 | -13.7% | 17,710 | -2.1% | 0.03% | -20.0% |
| Q3 2021 | $2,426,371 | -14.1% | 18,087 | +3.7% | 0.04% | -12.5% |
| Q2 2021 | $2,824,358 | +138.7% | 17,444 | +18.3% | 0.04% | +122.2% |
| Q1 2021 | $1,183,280 | +55.3% | 14,744 | +5.3% | 0.02% | +63.6% |
| Q4 2020 | $761,872 | +178.3% | 14,005 | +1.7% | 0.01% | +120.0% |
| Q3 2020 | $273,767 | -5.4% | 13,771 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $289,466 | +95.0% | 13,771 | +13.5% | 0.01% | +66.7% |
| Q1 2020 | $148,436 | -29.9% | 12,137 | -16.0% | 0.00% | -25.0% |
| Q4 2019 | $211,864 | +1.1% | 14,442 | -8.0% | 0.00% | 0.0% |
| Q3 2019 | $209,462 | +15.1% | 15,690 | +41.1% | 0.00% | +33.3% |
| Q2 2019 | $181,969 | -4.2% | 11,116 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $189,861 | +25.1% | 11,116 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $151,733 | -52.3% | 11,116 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $318,140 | -99.9% | 11,116 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $304,134,000 | +155.1% | 11,116 | +96.7% | 0.01% | +150.0% |
| Q1 2018 | $119,201,000 | +109258.7% | 5,652 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $109,000 | -60.2% | 5,652 | -48.7% | 0.00% | -50.0% |
| Q3 2017 | $274,000 | +55.7% | 11,016 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $176,000 | -7.4% | 11,016 | +24.0% | 0.00% | 0.0% |
| Q2 2016 | $190,000 | – | 8,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |